Literature DB >> 12925530

Neurotoxic, redox-competent Alzheimer's beta-amyloid is released from lipid membrane by methionine oxidation.

Kevin J Barnham1, Giuseppe D Ciccotosto, Anna K Tickler, Feda E Ali, Danielle G Smith, Nicholas A Williamson, Yuen-Han Lam, Darryl Carrington, Deborah Tew, Gulcan Kocak, Irene Volitakis, Frances Separovic, Colin J Barrow, John D Wade, Colin L Masters, Robert A Cherny, Cyril C Curtain, Ashley I Bush, Roberto Cappai.   

Abstract

The amyloid beta peptide is toxic to neurons, and it is believed that this toxicity plays a central role in the progression of Alzheimer's disease. The mechanism of this toxicity is contentious. Here we report that an Abeta peptide with the sulfur atom of Met-35 oxidized to a sulfoxide (Met(O)Abeta) is toxic to neuronal cells, and this toxicity is attenuated by the metal chelator clioquinol and completely rescued by catalase implicating the same toxicity mechanism as reduced Abeta. However, unlike the unoxidized peptide, Met(O)Abeta is unable to penetrate lipid membranes to form ion channel-like structures, and beta-sheet formation is inhibited, phenomena that are central to some theories for Abeta toxicity. Our results show that, like the unoxidized peptide, Met(O)Abeta will coordinate Cu2+ and reduce the oxidation state of the metal and still produce H2O2. We hypothesize that Met(O)Abeta production contributes to the elevation of soluble Abeta seen in the brain in Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12925530     DOI: 10.1074/jbc.M305494200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  Blood-borne amyloid-beta dimer correlates with clinical markers of Alzheimer's disease.

Authors:  Victor L Villemagne; Keyla A Perez; Kerryn E Pike; W Mei Kok; Christopher C Rowe; Anthony R White; Pierrick Bourgeat; Olivier Salvado; Justin Bedo; Craig A Hutton; Noel G Faux; Colin L Masters; Kevin J Barnham
Journal:  J Neurosci       Date:  2010-05-05       Impact factor: 6.167

2.  Structural and kinetic analysis of free methionine-R-sulfoxide reductase from Staphylococcus aureus: conformational changes during catalysis and implications for the catalytic and inhibitory mechanisms.

Authors:  Seoung Min Bong; Geun-Hee Kwak; Jin Ho Moon; Ki Seog Lee; Hong Seok Kim; Hwa-Young Kim; Young Min Chi
Journal:  J Biol Chem       Date:  2010-05-25       Impact factor: 5.157

3.  Despite its role in assembly, methionine 35 is not necessary for amyloid beta-protein toxicity.

Authors:  Panchanan Maiti; Aleksey Lomakin; George B Benedek; Gal Bitan
Journal:  J Neurochem       Date:  2010-03-20       Impact factor: 5.372

4.  Promotion of oxidative lipid membrane damage by amyloid beta proteins.

Authors:  Ian V J Murray; Michael E Sindoni; Paul H Axelsen
Journal:  Biochemistry       Date:  2005-09-20       Impact factor: 3.162

5.  CEREBRAL AMYLOID ANGIOPATHY AND ALZHEIMER'S DISEASE.

Authors:  Jorge Ghiso; Yasushi Tomidokoro; Tamas Revesz; Blas Frangione; Agueda Rostagno
Journal:  Hirosaki Igaku       Date:  2010-07-08

6.  A copper(I) protein possibly involved in the assembly of CuA center of bacterial cytochrome c oxidase.

Authors:  Lucia Banci; Ivano Bertini; Simone Ciofi-Baffoni; Efthalia Katsari; Nikolaos Katsaros; Karel Kubicek; Stefano Mangani
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-07       Impact factor: 11.205

Review 7.  How is protein aggregation in amyloidogenic diseases modulated by biological membranes?

Authors:  Christopher Aisenbrey; Tomasz Borowik; Roberth Byström; Marcus Bokvist; Fredrick Lindström; Hanna Misiak; Marc-Antoine Sani; Gerhard Gröbner
Journal:  Eur Biophys J       Date:  2007-11-21       Impact factor: 1.733

Review 8.  Delineating the mechanism of Alzheimer's disease A beta peptide neurotoxicity.

Authors:  Roberto Cappai; Kevin J Barnham
Journal:  Neurochem Res       Date:  2007-08-31       Impact factor: 3.996

9.  Capturing a reactive state of amyloid aggregates: NMR-based characterization of copper-bound Alzheimer disease amyloid β-fibrils in a redox cycle.

Authors:  Sudhakar Parthasarathy; Brian Yoo; Dan McElheny; William Tay; Yoshitaka Ishii
Journal:  J Biol Chem       Date:  2014-02-12       Impact factor: 5.157

10.  Endogenous zinc in neurological diseases.

Authors:  Jae-Yong Koh
Journal:  J Clin Neurol       Date:  2005-10-20       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.